NTRK2 and cancer: Previously, we demonstrated that induction of EMT programs by TrkB results in cancer acquiring metastatic potential by suppressing the SOCS3-mediated degradation of JAK2 that subsequently activates the PI3K/AKT and IL6/JAK2/STAT3 signaling pathways [16].